BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20099364)

  • 1. Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast-enhanced MRI: a pilot study.
    Notohamiprodjo M; Sourbron S; Staehler M; Michaely HJ; Attenberger UI; Schmidt GP; Boehm H; Horng A; Glaser C; Stief C; Reiser MF; Herrmann KA
    J Magn Reson Imaging; 2010 Feb; 31(2):490-501. PubMed ID: 20099364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging as a biomarker in renal cell carcinoma.
    Pedrosa I; Alsop DC; Rofsky NM
    Cancer; 2009 May; 115(10 Suppl):2334-45. PubMed ID: 19402070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
    Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
    Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined diffusion-weighted, blood oxygen level-dependent, and dynamic contrast-enhanced MRI for characterization and differentiation of renal cell carcinoma.
    Notohamiprodjo M; Staehler M; Steiner N; Schwab F; Sourbron SP; Michaely HJ; Helck AD; Reiser MF; Nikolaou K
    Acad Radiol; 2013 Jun; 20(6):685-93. PubMed ID: 23664397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadolinium-enhanced echo-planar T2-weighted MRI of tumors in the extracranial head and neck: feasibility study and preliminary results using a distributed-parameter tracer kinetic analysis.
    Bisdas S; Baghi M; Wagenblast J; Vogl TJ; Thng CH; Koh TS
    J Magn Reson Imaging; 2008 May; 27(5):963-9. PubMed ID: 18407543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
    Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
    Rosen MA; Schnall MD
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
    Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
    Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial spin labeling blood flow magnetic resonance imaging for the characterization of metastatic renal cell carcinoma(1).
    De Bazelaire C; Rofsky NM; Duhamel G; Michaelson MD; George D; Alsop DC
    Acad Radiol; 2005 Mar; 12(3):347-57. PubMed ID: 15766695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
    Toms AP; White LM; Kandel R; Bleakney RR; Noseworthy M; Lee S; Blackstein ME; Wunder J
    Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor perfusion assessed by dynamic contrast-enhanced MRI correlates to the grading of renal cell carcinoma: initial results.
    Palmowski M; Schifferdecker I; Zwick S; Macher-Goeppinger S; Laue H; Haferkamp A; Kauczor HU; Kiessling F; Hallscheidt P
    Eur J Radiol; 2010 Jun; 74(3):e176-80. PubMed ID: 19540690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of cryoablation on renal cell carcinoma perfusion and glomerular filtration rate measured using dynamic contrast-enhanced MRI: a feasibility study.
    Chapman SJ; Wah TM; Sourbron SP; Buckley DL
    Clin Radiol; 2013 Sep; 68(9):887-94. PubMed ID: 23639366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current role and future perspective of MRI for diagnosis and characterization of renal cell carcinoma.
    Schoth F; Persigehl T; Palmowski M
    Panminerva Med; 2010 Dec; 52(4):307-18. PubMed ID: 21183891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.
    Lüdemann L; Grieger W; Wurm R; Wust P; Zimmer C
    Magn Reson Imaging; 2005 Oct; 23(8):833-41. PubMed ID: 16275421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of tumor blood perfusion assessed by dynamic contrast-enhanced MRI with tumor blood supply assessed by invasive imaging.
    Graff BA; Benjaminsen IC; Brurberg KG; Ruud EB; Rofstad EK
    J Magn Reson Imaging; 2005 Mar; 21(3):272-81. PubMed ID: 15723369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic and dynamic renal imaging with assessment of glomerular filtration rate in a pcy-mouse model using a clinical 3.0 Tesla scanner.
    Sadick M; Schock D; Kraenzlin B; Gretz N; Schoenberg SO; Michaely HJ
    Invest Radiol; 2009 Aug; 44(8):469-75. PubMed ID: 19465861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of perfusion and permeability in breast tumors with a deconvolution-based analysis of second-bolus T1-DCE data.
    Makkat S; Luypaert R; Sourbron S; Stadnik T; De Mey J
    J Magn Reson Imaging; 2007 Jun; 25(6):1159-67. PubMed ID: 17520720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myocardial microcirculation in humans--new approaches using MRI].
    Wacker CM; Bauer WR
    Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
    Cheng HL; Wallis C; Shou Z; Farhat WA
    J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.